Peter Lin
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Radiomics and Machine Learning in Medical Imaging
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
Papers in
-
- Medical Imaging Techniques and Applications 15
- Radiopharmaceutical Chemistry and Applications 6
- MRI in cancer diagnosis 2
-
- Head and Neck Cancer Studies 11
- Co-authors
- Michael F. Lin (16 shared papers)Ivan Ho Shon (9 shared papers)Myo Min (10 shared papers)Dion F. Forstner (10 shared papers)Andrew Mark Scott (1 shared paper)Dishan H. Gunawardana (1 shared paper)Dylan L. Bartholomeusz (1 shared paper)Jayne E. Ramshaw (1 shared paper)
In The Last Decade
Peter Lin
41 papers receiving 1.7k citations
Peter Lin's Hit Papers
Peers
Comparison fields: 5 of 49
- Radiology, Nuclear Medicine and Imaging 1.2k
- Otorhinolaryngology 169
- Pulmonary and Respiratory Medicine 693
- Radiation 59
- Oncology 55
Countries citing papers authored by Peter Lin
This map shows the geographic impact of Peter Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lin more than expected).
Fields of papers citing papers by Peter Lin
This network shows the impact of papers produced by Peter Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lin. The network helps show where Peter Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial Hit paper breakdown → | 2021 | 853 |
| 2 | Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial Hit paper breakdown → | 2023 | 160 |
| 3 | [177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial Hit paper breakdown → | 2024 | 113 |
| 4 | Sequential [177Lu]Lu-PSMA-617 and docetaxel versus docetaxel in patients with metastatic hormone-sensitive prostate cancer (UpFrontPSMA): a multicentre, open-label, randomised, phase 2 study Hit paper breakdown → | 2024 | 82 |
| 5 | 2008 | 77 | |
| 6 | 2015 | 41 | |
| 7 | 2017 | 41 | |
| 8 | Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial Hit paper breakdown → | 2025 | 37 |
| 9 | 2011 | 27 | |
| 10 | 2016 | 27 | |
| 11 | 2016 | 26 | |
| 12 | 2015 | 24 | |
| 13 | 2000 | 20 | |
| 14 | 2025 | 19 | |
| 15 | 2010 | 18 | |
| 16 | Treatment response in liver metastases following 90Y SIR-spheres: an evaluation with PET. | 2007 | 17 |
| 17 | 2016 | 17 | |
| 18 | 2019 | 16 | |
| 19 | 2014 | 14 | |
| 20 | 2016 | 14 |
About Peter Lin
Peter Lin is a scholar working on Radiology, Nuclear Medicine and Imaging, Otorhinolaryngology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Radiation, having authored 42 papers that have together received 1.8k indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (15 papers), Head and Neck Cancer Studies (11 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Prostate Cancer Treatment and Research (6 papers), Lymphoma Diagnosis and Treatment (4 papers), Lung Cancer Diagnosis and Treatment (2 papers), MRI in cancer diagnosis (2 papers) and Thyroid Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (1.2k citations), Otorhinolaryngology (169 citations), Pulmonary and Respiratory Medicine (693 citations), Radiation (59 citations) and Oncology (55 citations). Peter Lin has collaborated with scholars based in Australia and Canada. Frequent co-authors include Michael F. Lin, Ivan Ho Shon, Myo Min, Dion F. Forstner, Andrew Mark Scott, Dishan H. Gunawardana, Dylan L. Bartholomeusz, Jayne E. Ramshaw, Victoria Bray and Lois Charlotte Holloway. Their work appears in journals such as British Journal of Radiology, The Lancet Oncology, Radiotherapy and Oncology, European Journal of Nuclear Medicine and Molecular Imaging and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.